TrialInvestigational new drugs2005
An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin.
R Goel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.